Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022

Authors

  • Salam Sawadogo Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso https://orcid.org/0000-0002-5243-6215
  • Yacouba Diallo Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
  • Koumpingnin Nebie Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
  • Bertrand Ivlabèhirè Meda Health Sciences Research Institute , Ouagadougou, Burkina Faso https://orcid.org/0000-0002-9717-3770
  • Corneille Ydriss Djerma Regional blood transfusion centre of Gaoua, Burkina Faso https://orcid.org/0009-0003-9329-2275
  • Georges Pengdwendé Ouedraogo Regional blood transfusion centre of Koudougou, Burkina Faso
  • Donatien Kima Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
  • Serge Mamadou Sawadogo Regional blood transfusion centre of Tenkodogo, Burkina Faso
  • Amadou Kafando Regional blood transfusion centre of Ouahigouya, Burkina Faso
  • Sinaré Coulibaly Regional blood transfusion centre of Ouagadougou, Burkina Faso https://orcid.org/0009-0001-0689-328X
  • Bachirou Cheickh Ashmed Nana Regional blood transfusion centre of Bobo-Dioulasso, Burkina Faso
  • Dieudonné Yetema Yonli Regional blood transfusion centre of Bobo-Dioulasso, Burkina Faso
  • Martin Ouedraogo Regional blood transfusion centre of Fada N'Gourma, Burkina Faso
  • Anita Pierrette Siritie Regional blood transfusion centre of Koudougou, Burkina Faso
  • Sylvie Zida Health Sciences Research Institute , Ouagadougou, Burkina Faso https://orcid.org/0000-0003-1727-2291
  • Charlemagne Sanhitouo Dabire Health Sciences Research Institute , Ouagadougou, Burkina Faso
  • Rakiatou Traore Regional blood transfusion centre of Kaya, Burkina Faso
  • Kadidiatou Aïna Konate Regional blood transfusion centre of Dédougou, Burkina Faso
  • Anita Benao Regional blood transfusion centre of Ouagadougou, Burkina Faso
  • Seimbou Zalla National Blood Transfusion Centre, Ouagadougou, Burkina Faso
  • Sonia Sontie National Blood Transfusion Centre, Ouagadougou, Burkina Faso
  • Veronique Deneys Catholic University of Louvain, Brussels, Belgium
  • Eléonore Kafando Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
  • Gautier Henri Ouedraogo Health Sciences Research Institute , Ouagadougou, Burkina Faso https://orcid.org/0000-0001-8566-7530

DOI:

https://doi.org/10.3855/jidc.18381

Keywords:

COVID-19, SARS-CoV-2, antibodies, blood donors, seroprevalence, Burkina Faso

Abstract

Introduction: In Sub-Saharan Africa, the true extent of the COVID-19 pandemic is not known due to the low number of tests performed and the large proportion of asymptomatic cases in the populations. This was a seroprevalence study of SARS-CoV-2 antibodies in blood donors to assess the extent of virus circulation in Burkina Faso.

Methodology: It was a cross-sectional study that included unpaid blood donors between March and April 2022. A rapid diagnostic test was used to screen SARS-CoV-2 antibodies in donors' plasma. Adjustment was made based on the performance of the test evaluated in a national quality control.

Results: A total of 3,084 blood donors were recruited, of whom 58.7% were male and 59.8% were from urban areas. The mean age was 22.9 ± 5.8 years, with donors aged 20 to 29 years accounting for 64.2%. The adjusted seroprevalence was 87.2%; 95% CI (86.4– 87.9). There was no difference in SARS-CoV-2 seropositivity between men and women, and between urban and rural areas. Donors aged 30-39 years had 0.5-fold lower odds of having SARS-CoV-2 antibodies than those under 20. Similarly, compared to Bobo-Dioulasso, blood donors from the Dédougou, Fada N'Gourma, and Koudougou centres had 0.5, 0.2, and 0.5 times lower odds of having SARS-CoV-2 antibodies, respectively.

Conclusions: The study indicates a high population exposure to SARS-CoV-2, in contrast with the official reports from the national surveillance system. It underscores the need to strengthen surveillance and public health interventions both in urban and rural areas.

Downloads

Published

2025-03-31

How to Cite

1.
Sawadogo S, Diallo Y, Nebie K, Meda BI, Djerma CY, Ouedraogo GP, Kima D, Sawadogo SM, Kafando A, Coulibaly S, Nana BCA, Yonli DY, Ouedraogo M, Siritie AP, Zida S, Dabire CS, Traore R, Konate KA, Benao A, Zalla S, Sontie S, Deneys V, Kafando E, Ouedraogo GH (2025) Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022. J Infect Dev Ctries 19:353–361. doi: 10.3855/jidc.18381

Issue

Section

Coronavirus Pandemic